drugset / Trial / NCT00411463

Psychotherapy for Bipolar II Depression, Pilot Study, Phase II

NCT00411463

RandomizedParallel-groupOpen-labelTreatment

Summary

Purpose of this study is to examine the effectiveness of an experimental psychotherapy (talk therapy) for the treatment of bipolar II depression. The name of this psychotherapy is Interpersonal and Social Rhythm Therapy for Bipolar II Depression (IPSRT-BPII). Subjects will be randomly assigned to receive either IPSRT-BPII or the medication Seroquel (quetiapine) to manage their symptoms of bipolar II depression. Subjects will receive the assigned therapy for up to 20 weeks.

Timeline

Start
2006-12
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 100 mg

Indications